Published in Eur J Pharmacol on May 03, 2000
Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci (2011) 1.02
Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats. Br J Pharmacol (2001) 0.95
Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P. Neuroscience (2008) 0.94
Antinociceptive effects of intraperitoneal and intrathecal vitamin e in the rat formalin test. Korean J Pain (2012) 0.94
Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol (Lausanne) (2013) 0.85
Investigation of the potentiation of the analgesic effects of fentanyl by ketamine in humans: a double-blinded, randomised, placebo controlled, crossover study of experimental pain[ISRCTN83088383]. BMC Anesthesiol (2005) 0.85
Antinociceptive interactions between intrathecal gabapentin and MK801 or NBQX in rat formalin test. J Korean Med Sci (2005) 0.82
Additive antinociception between intrathecal sildenafil and morphine in the rat formalin test. J Korean Med Sci (2008) 0.82
Antinociceptive drug interaction between intrathecal vitamin E and gabapentin in the rat formalin test. Korean J Anesthesiol (2012) 0.77
Selective antinociceptive effects of a combination of the N-methyl-D-aspartate receptor peptide antagonist [Ser(1)]histogranin and morphine in rat models of pain. Pharmacol Res Perspect (2014) 0.76
Antinociceptive effect of intrathecal sec-O-glucosylhamaudol on the formalin-induced pain in rats. Korean J Pain (2017) 0.75